Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis

Journal of Surgical Oncology

Volumn 79, Issue 4, 2002, Pages 230-235

  Yamaguchi, Akio ^a   Goi, Takanori ^a   Yu, Jiren ^b   Hirono, Yasuo ^a   Ishida, Makoto ^a   Iida, Atsushi ^a   Kimura, Toshihisa ^a   Takeuchi, Kazuo ^a   Katayama, Kanji ^a   Hirose, Kazuo ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b Wenzhou Medical University   (China)

Author keywords

CD44 variant exon 6; Gastric cancer; Hematogenous; Long term prognosis; Metastasis

Indexed keywords

CD44V ANTIGEN;

ADVANCED CANCER; ARTICLE; CANCER STAGING; CANCER SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; ANTIGENS, CD44; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; NEOPLASM CIRCULATING CELLS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0036207684     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10082     Document Type: Article

References (22)

1. CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines
2. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
3. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons
4. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain
5. Splicing choice from ten variant exons establishes CD44 variability
6. De-novo expression of CD44 and survival in gastric cancer
7. Soluble CD44 isoforms in serum as potential markers of metastatic carcinoma
8. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas
9. Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading
10. Expression of CD44 variant exons 8-10 in gastric cancer
11. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transeferase
12. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer
13. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression
14. Expression of CD44 variant 6 and lymphatic invasion: Importance to lymph node metastasis in gastric cancer
15. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer
16. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: Relevance with tumor progression
17. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis
18. Expression of CD44 variants and its association with survival in pancreatic cancer
19. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: Relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival
20. Expression and prognostic value of the CD44 splicing variant v5 and v6 in gastric cancer